Literature DB >> 11732550

Research on resistance to cancer drug Gleevec.

C L Sawyers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11732550     DOI: 10.1126/science.294.5548.1834b

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  9 in total

1.  Evolutionary dynamics of escape from biomedical intervention.

Authors:  Yoh Iwasa; Franziska Michor; Martin A Nowak
Journal:  Proc Biol Sci       Date:  2003-12-22       Impact factor: 5.349

2.  Nuclear accumulation of annexin A2 contributes to chromosomal instability by coilin-mediated centromere damage.

Authors:  T Kazami; H Nie; M Satoh; T Kuga; K Matsushita; N Kawasaki; T Tomonaga; F Nomura
Journal:  Oncogene       Date:  2014-10-27       Impact factor: 9.867

Review 3.  Targeting chronic myeloid leukemia stem cells.

Authors:  G Vignir Helgason; Graham A R Young; Tessa L Holyoake
Journal:  Curr Hematol Malig Rep       Date:  2010-04       Impact factor: 3.952

Review 4.  Genomic plasticity of the human fungal pathogen Candida albicans.

Authors:  Anna Selmecki; Anja Forche; Judith Berman
Journal:  Eukaryot Cell       Date:  2010-05-21

5.  Assaying Bcr-Abl kinase activity and inhibition in whole cell extracts by phosphorylation of substrates immobilized on agarose beads.

Authors:  Ding Wu; Evan Nair-Gill; Dorie A Sher; Laurie L Parker; Jennifer M Campbell; Mariah Siddiqui; Wendy Stock; Stephen J Kron
Journal:  Anal Biochem       Date:  2005-09-22       Impact factor: 3.365

Review 6.  On future's doorstep: RNA interference and the pharmacopeia of tomorrow.

Authors:  Alan M Gewirtz
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Factors determining sensitivity and resistance of tumor cells to arsenic trioxide.

Authors:  Serkan Sertel; Margaret Tome; Margaret M Briehl; Judith Bauer; Kai Hock; Peter K Plinkert; Thomas Efferth
Journal:  PLoS One       Date:  2012-05-10       Impact factor: 3.240

Review 8.  Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration.

Authors:  Ido Rippin; Hagit Eldar-Finkelman
Journal:  Cells       Date:  2021-01-29       Impact factor: 6.600

9.  The marine-derived oligosaccharide sulfate (MdOS), a novel multiple tyrosine kinase inhibitor, combats tumor angiogenesis both in vitro and in vivo.

Authors:  Jingui Ma; Xianliang Xin; Linghua Meng; Linjiang Tong; Liping Lin; Meiyu Geng; Jian Ding
Journal:  PLoS One       Date:  2008-11-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.